Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2363933

CN(C)CCC(CC(=O)c1ccc(-c2ccc(Nc3nc4ccc([N+](=O)[O-])cc4s3)cc2)cc1)C(=O)O.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.43
CSGALNACT1 Q8TDX6 1/20 0.43
KMT2A Q03164 5/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
LMNA P02545 3/20 0.43
NPY1R P25929 2/20 0.43
HTT P42858 2/20 0.43
S1PR2 O95136 1/20 0.43
NPY2R P49146 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
DYRK1A Q13627 1/20 0.42
MAPT P10636 4/20 0.42
MEN1 O00255 4/20 0.41
ALDH1A1 P00352 4/20 0.40
THRB P10828 2/20 0.40
POLB P06746 1/20 0.40
STAT1 P42224 1/20 0.40
MCL1 Q07820 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2363935 1.00 DGAT1 (0.43) DGAT1CSGALNACT1KMT2ASMN1; SMN2NPC1
SCHEMBL2306954 0.95 KMT2A (0.46) DGAT1CSGALNACT1KMT2ASMN1; SMN2NPC1
Trifluoroacetic Acid SCHEMBL2363303 0.88 DGAT1 (0.46) DGAT1CSGALNACT1KMT2ANPC1HTT
SCHEMBL1747966 0.82 DGAT1 (0.47) DGAT1CSGALNACT1KMT2ASMN1; SMN2NPC1
Trifluoroacetic Acid SCHEMBL2363691 0.82 NPC1 (0.43) DGAT1CSGALNACT1KMT2ASMN1; SMN2NPC1
SCHEMBL2307188 0.80 DYRK1A (0.52) DGAT1CSGALNACT1KMT2ASMN1; SMN2NPC1
SCHEMBL2306757 0.76 NPC1 (0.47) DGAT1CSGALNACT1KMT2ASMN1; SMN2NPC1
SCHEMBL1748025 0.73 DGAT1 (0.49) DGAT1CSGALNACT1NPC1DYRK1AMAPT
SCHEMBL12266255 0.73 LIPG (0.46) DGAT1CSGALNACT1KMT2ASMN1; SMN2NPC1
SCHEMBL2306330 0.71 SCD (0.58) DGAT1CSGALNACT1KMT2ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633722-B1 PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY BAYER HEALTHCARE LLC (US) 2011-08-03 EP disclosed
US-7423156-B2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity BAYER PHARMACEUTICALS CORPORATION (US) 2008-09-09 US disclosed
US-7091228-B2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity BAYER PHARMACEUTICALS CORPORATION (US) 2006-08-15 US disclosed